Video

PART 1: Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillation - Scope of the Problem and Key Challenges

Published: 21 May 2020

  • Views:

    Views Icon 39
  • Likes:

    Heart Icon 0

Prof Jan Steffel (Univerity He art Center, Zurich, CH), Prof Jur ten Berg (St Anthonius Hospital, Nieuwegein, NL) and Prof Stefan Hohnloser (JW Goethe University, Frankfurt, DE) discuss Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillaiton.